Drugs and diagnostics for superbugs, viruses and cancer

Superbugs and Inflammation: halting their advance

Every week in Australia 170 people lose their life to bacterial infection. Drug-resistant bacteria are now taking lives at an astonishing rate, and too few scientists are tackling the problem. An epidemic is coming, and we are unprepared.

Diseases like breast cancer and prostate cancer have the world in pursuit, but bacterial sepsis is killing more people every week than prostate, breast cancer and car accidents combined.

Bacteria have been evolving, and some have become so advanced that they can now evade antibiotics altogether, leaving us defenseless to fight them. They are aptly named ‘superbugs’.

Professor Matt Cooper is part of a small contingent of scientists in the world working to prevent the impending crisis.

Read more — research overview

Research projects

Research training opportunities

Featured publications

Engagement and impact

Partners and collaborators

Lab life gallery



Prof Matt Cooper

Professor Matthew Cooper

Director, IMB Centre for Superbug Solutions

Director, Community for Open Antimicrobial Drug Discovery

  +61 7 3346 2044  
  IMB Researcher Profile
  Centre for Superbug Solutions
  CO-ADD website

Partner with Professor Cooper

Support Professor Cooper's research

  Group Leader

  • Professor Matt Cooper

    Director, IMB Centre for Superbug Solutions
    Professorial Research Fellow - GL
    Institute for Molecular Bioscience